ertapenem has been researched along with Primary Peritonitis in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (43.48) | 29.6817 |
| 2010's | 12 (52.17) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Akbulut, I; Akkoçlu, G; Diniz, G; Göl Serin, B; Köse, Ş; Serin Senger, S; Serin, S; Yildirim, M; Yilmaz, O | 1 |
| Chen, G; Chen, LM; Li, XM | 1 |
| Amaduzzi, A; Ansaloni, L; Baiocchi, GL; Catena, F; Coccolini, F; Cucchi, M; Di Saverio, S; Lazzareschi, D; Pasqualini, E; Pinna, AD; Sartelli, M; Schiavina, R; Vallicelli, C | 1 |
| Bandettini, R; Buffa, P; Castagnola, E; Caviglia, I; Ciucci, A; Ginocchio, F; Guida, E; Haupt, R; Loy, A; Masa, DL; Mattioli, G; Perotti, M; Pini Prato, A | 1 |
| Cachero, A; Castellote, J; Dueñas, E; Girbau, A; Grau, I | 1 |
| Evans, D; Horn, P; Lee, P; Marsh, A; Slepavicius, A; Solomkin, J; Sutcliffe, JA; Tsai, L | 1 |
| Fernández, L; Gómez-Rice, A; Lillo, M; Maseda, E; Ramasco, F; Villagrán, MJ | 1 |
| Dibirov, MD; Fesenko, TA; Karsot'ian, GS; Khachatrian, NN; Poliakov, IA | 1 |
| García, E; García, FJ; García, JE; García, MB; García, MI; González, B; Lozano, FS | 1 |
| Badal, RE; Bouchillon, SK; Hawser, SP; Hoban, DJ | 1 |
| Boutbaoucht, M; Laghla, B; Nejmi, H; Samkaoui, MA | 1 |
| Ansaloni, L; Catena, F; Coccolini, F; Di Saverio, S; Ercolani, G; Gazzotti, F; Lazzareschi, D; Pinna, AD | 1 |
| Cady, A; Le Touvet, B; Mallédant, Y; Seguin, P; Tribut, O; Verdier, MC | 1 |
| Bereznitskiĭ, IaS; Bezdetko, NV | 1 |
| Couet, W; Grégoire, N; Marliat, M; Mimoz, O; Nordmann, P; Poirel, L | 1 |
| Chen, CC; Cheng, KC; Chiang, SR; Chiu, YH; Chuang, YC; Ko, WC; Ku, YH; Tang, HJ; Zhang, CC | 1 |
| Carides, A; Choe, KA; Christou, NV; Dellinger, EP; Fernandez, A; Malafaia, O; Rotstein, OD; Satishchandran, V; Solomkin, JS; Tellado, JM; Teppler, H; Yellin, AE | 1 |
| Zaĭtsev, AA | 1 |
| Asperger, W; Chan, CY; Dela Pena, AS; DiNubile, MJ; Giezek, H; Kafka, R; Köckerling, F; Raz, R; Shivaprakash, M; Vrijens, F; Warren, B | 1 |
| Burkhardt, O; Derendorf, H; Welte, T | 1 |
| Abramson, MA; Jensen, EH; Namias, N; Solomkin, JS; Tomassini, JE | 1 |
| Basoli, A; Chirletti, P; Cirino, E; D'Ovidio, NG; Doglietto, GB; Ecari, M; Giglio, D; Giulini, SM; Malizia, A; Petrovic, J; Taffurelli, M | 1 |
1 review(s) available for ertapenem and Primary Peritonitis
| Article | Year |
|---|---|
Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Critical Illness; Drug Interactions; Drug Resistance, Bacterial; Endometritis; Ertapenem; Female; Humans; Peritonitis; Protein Binding; Renal Insufficiency; Surgical Wound Infection; Urinary Tract Infections | 2007 |
10 trial(s) available for ertapenem and Primary Peritonitis
| Article | Year |
|---|---|
T.E.A. Study: three-day ertapenem versus three-day Ampicillin-Sulbactam.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Chi-Square Distribution; Drug Administration Schedule; Ertapenem; Female; Humans; Male; Middle Aged; Peritonitis; Sulbactam; Surgical Wound Infection; Treatment Outcome | 2013 |
Assessing the Efficacy and Safety of Eravacycline vs Ertapenem in Complicated Intra-abdominal Infections in the Investigating Gram-Negative Infections Treated With Eravacycline (IGNITE 1) Trial: A Randomized Clinical Trial.
Topics: Abdominal Abscess; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Appendicitis; Bacterial Infections; beta-Lactams; Double-Blind Method; Ertapenem; Female; Gram-Negative Bacteria; Humans; Intention to Treat Analysis; Male; Middle Aged; Peritonitis; Tetracyclines; Treatment Outcome; Young Adult | 2017 |
[Septic shock due to community-acquired complicated intra-abdominal infection treated with ertapenem: outcome in 25 cases].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Cohort Studies; Community-Acquired Infections; Critical Care; Emergencies; Ertapenem; Female; Hospital Mortality; Humans; Intestinal Perforation; Length of Stay; Male; Middle Aged; Peritonitis; Prospective Studies; Shock, Septic; Survival Analysis; Treatment Outcome | 2008 |
A prospective, multi centre, randomized clinical study to compare the efficacy and safety of Ertapenem 3 days versus Ampicillin-Sulbactam 3 days in the treatment of localized community acquired intra-abdominal infection. (T.E.A. Study: Three days Ertapene
Topics: Abdomen; Adult; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Protocols; Community-Acquired Infections; Drug Therapy, Combination; Ertapenem; Humans; Peritonitis; Sulbactam | 2011 |
Ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections: results of a double-blind, randomized comparative phase III trial.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Digestive System Surgical Procedures; Double-Blind Method; Drug Therapy, Combination; Ertapenem; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitalization; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Research Design; Treatment Outcome | 2003 |
[Carbapenem antibiotic ertapenem in the treatment of extrahospital intraabdominal infections].
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Prospective Studies; Tazobactam; Treatment Outcome | 2003 |
[Efficacy of invanz proven in the treatment of intra-abdominal infections in one of the largest studies yet conducted on surgical patients].
Topics: beta-Lactams; Ertapenem; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Lactams; Peritonitis; Postoperative Complications; Treatment Outcome | 2003 |
Efficacy and safety of ertapenem versus piperacillin-tazobactam for the treatment of intra-abdominal infections requiring surgical intervention.
Topics: Abdomen; Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Diarrhea; Ertapenem; Escherichia coli Infections; Female; Gastrointestinal Diseases; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Treatment Outcome | 2006 |
Randomized, multicenter, double-blind study of efficacy, safety, and tolerability of intravenous ertapenem versus piperacillin/tazobactam in treatment of complicated intra-abdominal infections in hospitalized adults.
Topics: Abdominal Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; APACHE; Bacterial Infections; Bacteroides; beta-Lactams; Double-Blind Method; Ertapenem; Escherichia coli; Female; Humans; Male; Middle Aged; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination | 2007 |
A prospective, double-blind, multicenter, randomized trial comparing ertapenem 3 vs >or=5 days in community-acquired intraabdominal infection.
Topics: Anti-Bacterial Agents; APACHE; Appendicitis; beta-Lactams; Community-Acquired Infections; Double-Blind Method; Ertapenem; Humans; Peritonitis; Prospective Studies; Surgical Wound Infection | 2008 |
12 other study(ies) available for ertapenem and Primary Peritonitis
| Article | Year |
|---|---|
An evaluation of the effect of ertapenem in rats with sepsis created by cecal ligation and puncture.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Ertapenem; Peritonitis; Random Allocation; Rats; Rats, Wistar; Sepsis | 2019 |
[The 473rd case: renal failure, abdominal pain, and mental abnormality].
Topics: Abdominal Pain; Adult; Anti-Bacterial Agents; Ertapenem; Gastroenteritis; Humans; Korsakoff Syndrome; Male; Mental Disorders; Peritoneal Dialysis; Peritonitis; Renal Insufficiency; Thiamine; Treatment Outcome; Wernicke Encephalopathy | 2020 |
Susceptibility to antibiotics of aerobic bacteria isolated from community acquired secondary peritonitis in children: therapeutic guidelines might not always fit with and everyday experience.
Topics: Ampicillin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Child; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Gentamicins; Hospitals, Pediatric; Humans; Italy; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Practice Guidelines as Topic; Sulbactam; Thienamycins | 2013 |
Ertapenem failure as therapy for nosocomial spontaneous bacterial peritonitis.
Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Substitution; Ertapenem; Escherichia coli; Escherichia coli Infections; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Hepatorenal Syndrome; Humans; Klebsiella Infections; Klebsiella pneumoniae; Liver Transplantation; Male; Middle Aged; Peritonitis; Postoperative Complications; Treatment Failure | 2016 |
[Ertapenem in combined therapy for generalized peritonitis].
Topics: Anti-Bacterial Agents; beta-Lactams; Combined Modality Therapy; Ertapenem; Humans; Peritonitis | 2008 |
[Activity of Ertapenem and Ceftriaxone in the eradication of Salmonella in a model of experimental peritonitis in mice].
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Dose-Response Relationship, Drug; Ertapenem; Male; Mice; Peritonitis; Salmonella enterica; Salmonella Infections | 2009 |
Epidemiologic trends, occurrence of extended-spectrum beta-lactamase production, and performance of ertapenem and comparators in patients with intra-abdominal infections: analysis of global trend data from 2002-2007 from the SMART study.
Topics: Africa; Animals; Anti-Bacterial Agents; Asia; Australasia; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Ertapenem; Europe; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Latin America; Middle East; North America; Peritonitis | 2010 |
[Evolution of Escherichia coli resistance in community acquired peritonitis].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Appendicitis; beta-Lactams; Cephalosporins; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Female; Humans; Intestines; Male; Morocco; Peptic Ulcer Perforation; Peritonitis; Practice Guidelines as Topic; Prospective Studies | 2011 |
Ertapenem in plasma and peritoneal fluid from patients with severe intra-abdominal infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ascitic Fluid; beta-Lactams; Ertapenem; Female; Humans; Intensive Care Units; Male; Middle Aged; Peritonitis; Plasma | 2011 |
[Clinical-economic analysis of antibacterial therapy of acute peritonitis].
Topics: Acute Disease; Anti-Bacterial Agents; beta-Lactams; Clinical Trials as Topic; Cost-Benefit Analysis; Decision Trees; Drug Therapy, Combination; Ertapenem; Health Care Costs; Humans; Models, Theoretical; Peritonitis; Treatment Outcome | 2011 |
Broad-spectrum β-lactam antibiotics for treating experimental peritonitis in mice due to Klebsiella pneumoniae producing the carbapenemase OXA-48.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Cefotaxime; Ceftazidime; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Ertapenem; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Lethal Dose 50; Mice; Penicillanic Acid; Peritonitis; Piperacillin; Piperacillin, Tazobactam Drug Combination; Plasmids; Survival Rate | 2012 |
Use of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies.
Topics: Animals; beta-Lactams; Carbapenems; Cell Line; Doripenem; Ertapenem; Female; Imipenem; Meropenem; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Peritonitis; Salmonella; Thienamycins | 2012 |